BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7551027)

  • 1. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine.
    Delvig AA; Wedege E; Caugant DA; Dalseg R; Kolberg J; Achtman M; Rosenqvist E
    Microbiology (Reading); 1995 Jul; 141 ( Pt 7)():1593-600. PubMed ID: 7551027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine-induced IgG antibodies to the linear epitope on the PorB outer membrane protein promote opsonophagocytosis of Neisseria meningitidis by human neutrophils.
    Delvig AA; Michaelsen TE; Aase A; Hoiby EA; Rosenqvist E
    Clin Immunol Immunopathol; 1997 Jul; 84(1):27-35. PubMed ID: 9191881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
    Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J
    Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to linear epitopes on the PorB protein of Neisseria meningitidis in patients with systemic meningococcal disease.
    Delvig AA; Wedege E; Michaelsen TE; Høiby EA; Brandtzaeg P; Rosenqvist E
    Microbiology (Reading); 1996 Sep; 142 ( Pt 9)():2491-8. PubMed ID: 8828216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.
    Naess LM; Aarvak T; Aase A; Oftung F; Høiby EA; Sandin R; Michaelsen TE
    Vaccine; 1999 Feb; 17(7-8):754-64. PubMed ID: 10067680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.
    Wedege E; Høiby EA; Rosenqvist E; Bjune G
    Infect Immun; 1998 Jul; 66(7):3223-31. PubMed ID: 9632589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van der Ley P; van der Biezen J; George S; Tunnela O; van Dijken H; Kuipers B; Poolman J
    Infect Immun; 1996 Jul; 64(7):2745-51. PubMed ID: 8698504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
    Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
    Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.
    Naess LM; Oftung F; Aase A; Wetzler LM; Sandin R; Michaelsen TE
    Infect Immun; 1998 Mar; 66(3):959-65. PubMed ID: 9488382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.
    Matthias KA; Reveille A; Connolly KL; Jerse AE; Gao YS; Bash MC
    Vaccine; 2020 Feb; 38(10):2396-2405. PubMed ID: 32037226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis.
    Christodoulides M; Heckels JE
    Microbiology (Reading); 1994 Nov; 140 ( Pt 11)():2951-60. PubMed ID: 7529096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements.
    Wiertz EJ; van Gaans-van den Brink JA; Schreuder GM; Termijtelen AA; Hoogerhout P; Poolman JT
    J Immunol; 1991 Sep; 147(6):2012-8. PubMed ID: 1716291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine.
    Oftung F; Naess LM; Wetzler LM; Korsvold GE; Aase A; Høiby EA; Dalseg R; Holst J; Michaelsen TE; Haneberg B
    Infect Immun; 1999 Feb; 67(2):921-7. PubMed ID: 9916109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination.
    Sjursen H; Wedege E; Rosenqvist E; Naess A; Halstensen A; Matre R; Solberg CO
    APMIS; 1990 Dec; 98(12):1061-9. PubMed ID: 2126441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG antibody subclass responses determined by immunoblot in infants' sera following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine.
    Martin S; Sadler F; Borrow R; Dawson M; Fox A; Cartwright K
    Vaccine; 2001 Aug; 19(31):4404-8. PubMed ID: 11483265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and immunologic characterization of a novel serotype 4, 15 strain of Neisseria meningitidis.
    Bash MC; Lynn F; Concepcion NF; Tappero JW; Carlone GM; Frasch CE
    FEMS Immunol Med Microbiol; 2000 Nov; 29(3):169-76. PubMed ID: 11064262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
    Rollier CS; Dold C; Marsay L; Linder A; Green CA; Sadarangani M; Norheim G; Derrick JP; Feavers IM; Maiden MCJ; Pollard AJ
    mSphere; 2022 Feb; 7(1):e0067421. PubMed ID: 35080470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
    Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of IgG subclass antibody responses after immunization with a group B meningococcal outer membrane vesicle vaccine, using monoclonal mouse-human chimeric antibodies as standards.
    Naess LM; Rosenqvist E; Høiby EA; Michaelsen TE
    J Immunol Methods; 1996 Sep; 196(1):41-9. PubMed ID: 8841442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.